BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 6, Issue 4
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (7188)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.
Item 
Count 
PDF447
WORD291
HTML4402
Figures (1-1)130
Tables (1-2)142
 Sum=5412
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse996
Download780
 Sum=1776
Apr 27, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Ozturk ZA, Kadayifci A. Insulin sensitizers for the treatment of non-alcoholic fatty liver disease. World J Hepatol 2014; 6(4): 199-206 [PMID: 24799988 DOI: 10.4254/wjh.v6.i4.199]
URL: https://www.wjgnet.com/1948-5182/full/v6/i4/199.htm
Number Citing Articles
1
Sung Hyun Lee, Dongwan Kim, Min Young Baek, Hann Tchah, Yeon Sun Kim, Eell Ryoo, Yun Mi Kim. Abdominal Subcutaneous Fat Thickness Measured by Ultrasonography Correlates with Hyperlipidemia and Steatohepatitis in Obese Children. Pediatric Gastroenterology, Hepatology & Nutrition 2015; 18(2): 108 doi: 10.5223/pghn.2015.18.2.108
2
Kyung-A Hwang, Yu-Jin Hwang, Ga Ram Kim, Jeong-Sook Choe. Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity. BMC Complementary and Alternative Medicine 2015; 15(1) doi: 10.1186/s12906-015-0871-5
3
Wang-Hsin Lee, Sonia M. Najjar, C. Ronald Kahn, Terry D. Hinds. Hepatic insulin receptor: new views on the mechanisms of liver disease. Metabolism 2023; 145: 155607 doi: 10.1016/j.metabol.2023.155607
4
Izabelle Barcellos Santos, Graziele Freitas de Bem, Viviane Silva Cristino Cordeiro, Cristiane Aguiar da Costa, Lenize Costa Reis Marins de Carvalho, Ana Paula Machado da Rocha, Gisele França da Costa, Dayane Teixeira Ognibene, Roberto Soares de Moura, Angela Castro Resende. Supplementation with Vitis vinifera L. skin extract improves insulin resistance and prevents hepatic lipid accumulation and steatosis in high-fat diet–fed mice. Nutrition Research 2017; 43: 69 doi: 10.1016/j.nutres.2017.05.007
5
Gavin Hamilton, Michael S. Middleton, Elhamy R. Heba, Claude B. Sirlin. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. 2019; : 141 doi: 10.1007/978-3-030-11748-1_6
6
Sudha S. Shankar, R. Ravi Shankar, Radha A. Railkar, Chan R. Beals, Helmut O. Steinberg, David E. Kelley. Early Clinical Detection of Pharmacologic Response in Insulin Action in a Nondiabetic Insulin-Resistant Population. Current Therapeutic Research 2015; 77: 83 doi: 10.1016/j.curtheres.2015.08.001
7
Dan Wu, Venkateswararao Eeda, Ram Babu Undi, Shivani Mann, Michael Stout, Hui-Ying Lim, Weidong Wang. A novel peroxisome proliferator-activated receptor gamma ligand improves insulin sensitivity and promotes browning of white adipose tissue in obese mice. Molecular Metabolism 2021; 54: 101363 doi: 10.1016/j.molmet.2021.101363
8
Hua Yan, Yan-Qiong Gao, Ying Zhang, Huan Wang, Gui-Sheng Liu, Jian-Yuan Lei. Chlorogenic acid alleviates autophagy and insulin resistance by suppressing JNK pathway in a rat model of nonalcoholic fatty liver disease. Journal of Biosciences 2018; 43(2): 287 doi: 10.1007/s12038-018-9746-5
9
Shehab M Abd El-Kader, Eman M Salah El-Den Ashmawy. Non-alcoholic fatty liver disease: The diagnosis and management. World Journal of Hepatology 2015; 7(6): 846-858 doi: 10.4254/wjh.v7.i6.846
10
Xiaole Li, Jia Li, Lulu Wang, Aiyun Li, Zhixia Qiu, Lian‐wen Qi, Junping Kou, Kang Liu, Baolin Liu, Fang Huang. The role of metformin and resveratrol in the prevention of hypoxia‐inducible factor 1α accumulation and fibrosis in hypoxic adipose tissue. British Journal of Pharmacology 2016; 173(12): 2001 doi: 10.1111/bph.13493
11
Paola Solinas, Michela Isola, Maria Alberta Lilliu, Gabriele Conti, Alberto Civolani, Luigi Demelia, Francesco Loy, Raffaella Isola. Animal models are reliably mimicking human diseases? A morphological study that compares animal with human NAFLD. Microscopy Research and Technique 2014; 77(10): 790 doi: 10.1002/jemt.22401
12
Lizhi Fu, Antje Bruckbauer, Fenfen Li, Qiang Cao, Xin Cui, Rui Wu, Hang Shi, Michael B. Zemel, Bingzhong Xue. Interaction between metformin and leucine in reducing hyperlipidemia and hepatic lipid accumulation in diet-induced obese mice. Metabolism 2015; 64(11): 1426 doi: 10.1016/j.metabol.2015.07.006
13
Eduardo García Díaz, Danila Guagnozzi, Verónica Gutiérrez, Carmen Mendoza, Cristina Maza, Yulene Larrañaga, Dolores Perdomo, Teresa Godoy, Ghalli Taleb. Efecto de las terapias incretínicas comparadas con pioglitazona y gliclazida en la esteatosis hepática no alcohólica de los pacientes diabéticos no controlados solo con metformina: estudio observacional piloto. Endocrinología y Nutrición 2016; 63(5): 194 doi: 10.1016/j.endonu.2016.01.006
14
Sayali Bhave, Han Kiat Ho. Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Non-Alcoholic Fatty Liver Disease. Biomedicines 2021; 9(12): 1776 doi: 10.3390/biomedicines9121776
15
Naoto Okada, Shinya Kobayashi, Kouta Moriyama, Kohsuke Miyataka, Shinji Abe, Chiemi Sato, Kazuyoshi Kawazoe. Helianthus tuberosus (Jerusalem artichoke) tubers improve glucose tolerance and hepatic lipid profile in rats fed a high-fat diet. Asian Pacific Journal of Tropical Medicine 2017; 10(5): 439 doi: 10.1016/j.apjtm.2017.03.028
16
Bin Li, Qi Xiao, Jianuo Zhang, Yumeng Wang, Jiushi Liu, Bengang Zhang, Haitao Liu. Exploring the active compounds and potential mechanism of the anti-nonalcoholic fatty liver disease activity of the fraction from Schisandra chinensis fruit extract based on multi-technology integrated network pharmacology. Journal of Ethnopharmacology 2023; 301: 115769 doi: 10.1016/j.jep.2022.115769
17
N. Chalasani, R. Vuppalanchi, M. Rinella, M. S. Middleton, M. S. Siddiqui, A. S. Barritt, O. Kolterman, O. Flores, C. Alonso, M. Iruarrizaga‐Lejarreta, R. Gil‐Redondo, C. B. Sirlin, M. B. Zemel. Randomised clinical trial: a leucine‐metformin‐sildenafil combination (NS‐0200) vs placebo in patients with non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2018; 47(12): 1639 doi: 10.1111/apt.14674
18
Laila Naif Al-Harbi, Ghedeir M. Alshammari, Alhanouf Mohammed Al-Dossari, Pandurangan Subash-Babu, Manal Abdulaziz Binobead, Maha H. Alhussain, Sahar Abdulaziz AlSedairy, Doha M. Al-Nouri, Ghalia Shamlan. Beta vulgaris L. (Beetroot) Methanolic Extract Prevents Hepatic Steatosis and Liver Damage in T2DM Rats by Hypoglycemic, Insulin-Sensitizing, Antioxidant Effects, and Upregulation of PPARα. Biology 2021; 10(12): 1306 doi: 10.3390/biology10121306
19
Wenya Meng, Zitong Zhao, Lingli Chen, Suyun Lin, Yang Zhang, Jing He, Kehui Ouyang, Wenjun Wang. Total Flavonoids from Chimonanthus nitens Oliv. Leaves Ameliorate HFD-Induced NAFLD by Regulating the Gut–Liver Axis in Mice. Foods 2022; 11(14): 2169 doi: 10.3390/foods11142169
20
Eduardo García Díaz, Danila Guagnozzi, Verónica Gutiérrez, Carmen Mendoza, Cristina Maza, Yulene Larrañaga, Dolores Perdomo, Teresa Godoy, Ghalli Taleb. Effect of incretin therapies compared to pioglitazone and gliclazide in non-alcoholic fatty liver disease in diabetic patients not controlled on metformin alone: An observational, pilot study. Endocrinología y Nutrición (English Edition) 2016; 63(5): 194 doi: 10.1016/j.endoen.2016.05.008
21
Xianghui Huang, Jia Xu, Yingxin Hu, Kunlun Huang, Yunbo Luo, Xiaoyun He. Broccoli ameliorate NAFLD by increasing lipolysis and promoting liver macrophages polarize toward M2-type. Journal of Functional Foods 2022; 89: 104898 doi: 10.1016/j.jff.2021.104898
22
Pei-Jie Chen, Shuang-Peng Cai, Cheng Huang, Xiao-Ming Meng, Jun Li. Protein tyrosine phosphatase 1B (PTP1B): A key regulator and therapeutic target in liver diseases. Toxicology 2015; 337: 10 doi: 10.1016/j.tox.2015.08.006
23
Michael B. Zemel. Natural Products: New Hope for Nonalcoholic Steatohepatitis?. Journal of Medicinal Food 2019; 22(12): 1187 doi: 10.1089/jmf.2019.29004.mbz
24
Havva Afshari, Shokoofe Noori, Afshin Zarghi. Hepatic Steatosis Alleviated by a Novel Metformin and Quercetin Combination Activating Autophagy Through the cAMP/AMPK/SIRT1 Pathway. Iranian Journal of Pharmaceutical Research 2023; 22(1) doi: 10.5812/ijpr-136952
25
Gehan H. Heeba, Reham M. El-Deen, Rania G. Abdel-latif, Mohamed M.A. Khalifa. Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study. Canadian Journal of Physiology and Pharmacology 2020; 98(8): 498 doi: 10.1139/cjpp-2019-0487
26
Mehran Rahimlou, Hoda Ahmadnia, Azita Hekmatdoost. Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the future. World Journal of Hepatology 2015; 7(25): 2597-2602 doi: 10.4254/wjh.v7.i25.2597
27
Joel T. Haas, Sven Francque, Bart Staels. Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease. Annual Review of Physiology 2016; 78(1): 181 doi: 10.1146/annurev-physiol-021115-105331
28
Ans Jacobs, Anne‐Sophie Warda, Jef Verbeek, David Cassiman, Pieter Spincemaille. An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to Present. Current Protocols in Mouse Biology 2016; 6(2): 185 doi: 10.1002/cpmo.3
29
Anabel García-Heredia, Marta Riera-Borrull, Isabel Fort-Gallifa, Fedra Luciano-Mateo, Noemí Cabré, Anna Hernández-Aguilera, Jorge Joven, Jordi Camps. Metformin administration induces hepatotoxic effects in paraoxonase-1-deficient mice. Chemico-Biological Interactions 2016; 249: 56 doi: 10.1016/j.cbi.2016.03.004
30
Havva Afshari, Shokoofe Noori, Afshin Zarghi. A novel combination of metformin and resveratrol alleviates hepatic steatosis by activating autophagy through the cAMP/AMPK/SIRT1 signaling pathway. Naunyn-Schmiedeberg's Archives of Pharmacology 2023; 396(11): 3135 doi: 10.1007/s00210-023-02520-7
31
Rui-Bing Feng, Chun-Lin Fan, Qing Liu, Zhong Liu, Wei Zhang, Yao-Lan Li, Wei Tang, Ying Wang, Man-Mei Li, Wen-Cai Ye. Crude triterpenoid saponins from Ilex latifolia (Da Ye Dong Qing) ameliorate lipid accumulation by inhibiting SREBP expression via activation of AMPK in a non-alcoholic fatty liver disease model. Chinese Medicine 2015; 10(1) doi: 10.1186/s13020-015-0054-9
32
Kun Xie, Xi He, Keyu Chen, Kozue Sakao, De-Xing Hou. Ameliorative effects and molecular mechanisms of vine tea on western diet-induced NAFLD. Food & Function 2020; 11(7): 5976 doi: 10.1039/D0FO00795A
33
V. T. Ivashkin, Marina V. Mayevskaya, Ch. S. Pavlov, I. N. Tikhonov, Ye. N. Shirokova, A. O. Buyeverov, O. M. Drapkina, Yu. O. Shulpekova, V. V. Tsukanov, S. N. Mammayev, I. V. Mayev, L. K. Palgova. Diagnostics and treatment of non-alcoholic fatty liver disease: clinical guidelines of the Russian Scientific Liver Society and the Russian gastroenterological association. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2016; 26(2): 24 doi: 10.22416/1382-4376-2016-26-2-24-42
34
Giovanni Brandi, Stefania De Lorenzo, Marco Candela, Maria Abbondanza Pantaleo, Stefano Bellentani, Francesco Tovoli, Gioconda Saccoccio, Guido Biasco. Microbiota, NASH, HCC and the potential role of probiotics. Carcinogenesis 2017; 38(3): 231 doi: 10.1093/carcin/bgx007
35
María del Carmen Baez, Mariana Tarán, Mónica Moya, María de la Paz Scribano Parada. Modulation of Oxidative Stress in Heart Disease. 2019; : 313 doi: 10.1007/978-981-13-8946-7_12
36
Nengguang Fan, Lijuan Zhang, Zhenhua Xia, Liang Peng, Yufan Wang, Yongde Peng. Sex-Specific Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients. Journal of Diabetes Research 2016; 2016: 1 doi: 10.1155/2016/3805372
37
K W ter Horst, P W Gilijamse, K E Koopman, B A de Weijer, M Brands, R S Kootte, J A Romijn, M T Ackermans, M Nieuwdorp, M R Soeters, M J Serlie. Insulin resistance in obesity can be reliably identified from fasting plasma insulin. International Journal of Obesity 2015; 39(12): 1703 doi: 10.1038/ijo.2015.125
38
Cosimo Colletta, Alessandro Colletta, Giuseppe Placentino. Lifestyle and silymarin: a fight against liver damage in NAFLD associated - prediabetic disease. Journal of Diabetes & Metabolic Disorders 2020; 19(2): 883 doi: 10.1007/s40200-020-00576-3
39
Andrew J. Krentz, Angelo Scuteri. Diabetes in Old Age. 2017; : 177 doi: 10.1002/9781118954621.ch15
40
V. P. Prysyazhnyuk, Z. I. Rossokha, N. G. Gorovenko. Variation in particular biochemical indicators, cytokine and adipokine profiles of the blood, and the structural and functional parameters of the liver in patients with nonalcoholic fatty liver disease and different genotypes by the polymorphic locus A313G of the GSTP1 gene. Cytology and Genetics 2017; 51(6): 455 doi: 10.3103/S0095452717060111
41
Mahdi Ramezani Binabaj, Mohsen Motalebi, Hamid Karimi-Sari, Mohammad Saeid Rezaee Zavareh, Seyed Moayed Alavian. Are Women With Polycystic Ovarian Syndrome at a High Risk of Non-Alcoholic Fatty Liver Disease? A Meta-Analysis. Hepatitis Monthly 2014; 14(11) doi: 10.5812/hepatmon.23235
42
Da Eun Kim, Bo Yoon Chang, Byeong Min Jeon, Jong In Baek, Sun Chang Kim, Sung Yeon Kim. SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway. International Journal of Molecular Sciences 2020; 21(12): 4534 doi: 10.3390/ijms21124534
43
Guojing Liu, Jiagen Wen, Dong Guo, Zhenmin Wang, Xiaolei Hu, Jie Tang, Zhaoqian Liu, Honghao Zhou, Wei Zhang. The effects of rabeprazole on metformin pharmacokinetics and pharmacodynamics in Chinese healthy volunteers. Journal of Pharmacological Sciences 2016; 132(4): 244 doi: 10.1016/j.jphs.2016.04.016
44
Pingping Luo, Ming Zheng, Rui Zhang, Hong Zhang, Yingxia Liu, Wei Li, Xiaoming Sun, Qian Yu, George L. Tipoe, Jia Xiao. S-Allylmercaptocysteine improves alcoholic liver disease partly through a direct modulation of insulin receptor signaling. Acta Pharmaceutica Sinica B 2021; 11(3): 668 doi: 10.1016/j.apsb.2020.11.006
45
Joost Boeckmans, Alessandra Natale, Matthias Rombaut, Karolien Buyl, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Robim M. Rodrigues. Anti-NASH Drug Development Hitches a Lift on PPAR Agonism. Cells 2019; 9(1): 37 doi: 10.3390/cells9010037
46
Amarjeet Singh, Shalini Gainder, Pradipta Banerjee, Apurva Goel, Pawan Kumar, Banashree Mondal, Samudra P. Banik, Debasis Bagchi. Efficacy of a Proprietary Fenugreek Seed Extract (Trigonella foenum-graecum, Furocyst®) in Women with Polycystic Ovary Syndrome (PCOS): a Randomized, Double-Blind, Placebo-Controlled Study. Journal of the American Nutrition Association 2023; 42(7): 651 doi: 10.1080/27697061.2022.2126410
47
Lucy Petagine, Mohammed Gulrez Zariwala, Vinood B Patel. Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments. World Journal of Gastroenterology 2023; 29(32): 4831-4850 doi: 10.3748/wjg.v29.i32.4831
48
Claudia Della Corte, Daniela Liccardo, Federica Ferrari, Anna Alisi, Valerio Nobili. Current pharmacotherapy for treating pediatric nonalcoholic fatty liver disease. Expert Opinion on Pharmacotherapy 2014; 15(17): 2501 doi: 10.1517/14656566.2014.960389
49
Alejandro Campos-Murguía, Astrid Ruiz-Margáin, José A González-Regueiro, Ricardo U Macías-Rodríguez. Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease. World Journal of Gastroenterology 2020; 26(39): 5919-5943 doi: 10.3748/wjg.v26.i39.5919
50
Gavin Hamilton, Michael S. Middleton, Elhamy R. Heba, Claude B. Sirlin. Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development. 2015; : 99 doi: 10.1007/978-1-4471-4920-0_4
51
Huong Thi Nguyen, Mingkun Gu, Pia Werlinger, Joo-Hyung Cho, Jinhua Cheng, Joo-Won Suh. Lactobacillus sakei MJM60958 as a Potential Probiotic Alleviated Non-Alcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet by Modulating Lipid Metabolism, Inflammation, and Gut Microbiota. International Journal of Molecular Sciences 2022; 23(21): 13436 doi: 10.3390/ijms232113436
52
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 2016; 65(8): 1109 doi: 10.1016/j.metabol.2016.05.003
53
Eun Mi Ahn, Gelila Asamenew, Heon Woong Kim, Sang Hoon Lee, Seon-Mi Yoo, Soo-Muk Cho, Youn-Soo Cha, Min-Sook Kang. Anti-Obesity Effects of Petasites japonicus (Meowi) Ethanol Extract on RAW 264.7 Macrophages and 3T3-L1 Adipocytes and Its Characterization of Polyphenolic Compounds. Nutrients 2020; 12(5): 1261 doi: 10.3390/nu12051261
54
Gisele França da Costa, Izabelle Barcellos Santos, Graziele Freitas de Bem, Viviane Silva Cristino Cordeiro, Cristiane Aguiar da Costa, Lenize Costa Reis Marins de Carvalho, Dayane Teixeira Ognibene, Angela Castro Resende, Roberto Soares de Moura. The Beneficial Effect of Anthocyanidin‐Rich Vitis vinifera L. Grape Skin Extract on Metabolic Changes Induced by High‐Fat Diet in Mice Involves Antiinflammatory and Antioxidant Actions. Phytotherapy Research 2017; 31(10): 1621 doi: 10.1002/ptr.5898
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345